DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination
Top Cited Papers
Open Access
- 26 January 2014
- journal article
- research article
- Published by Springer Nature in Nature Nanotechnology
- Vol. 9 (2) , 148-155
Abstract
The assembly of nanomaterials using DNA can produce complex nanostructures, but the biological applications of these structures remain unexplored. Here, we describe the use of DNA to control the biological delivery and elimination of inorganic nanoparticles by organizing them into colloidal superstructures. The individual nanoparticles serve as building blocks, whose size, surface chemistry and assembly architecture dictate the overall superstructure design. These superstructures interact with cells and tissues as a function of their design, but subsequently degrade into building blocks that can escape biological sequestration. We demonstrate that this strategy reduces nanoparticle retention by macrophages and improves their in vivo tumour accumulation and whole-body elimination. Superstructures can be further functionalized to carry and protect imaging or therapeutic agents against enzymatic degradation. These results suggest a different strategy to engineer nanostructure interactions with biological systems and highlight new directions in the design of biodegradable and multifunctional nanomedicine.Keywords
This publication has 34 references indexed in Scilit:
- A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dotsNature Nanotechnology, 2012
- Luminescent Gold Nanoparticles with Efficient Renal ClearanceAngewandte Chemie International Edition, 2011
- Scavenger Receptors Mediate Cellular Uptake of Polyvalent Oligonucleotide-Functionalized Gold NanoparticlesBioconjugate Chemistry, 2010
- Gold Nanoparticles for Biology and MedicineAngewandte Chemie International Edition, 2010
- Cooperative nanomaterial system to sensitize, target, and treat tumorsProceedings of the National Academy of Sciences, 2009
- Design considerations for tumour-targeted nanoparticlesNature Nanotechnology, 2009
- Bioconjugated quantum dots for in vivo molecular and cellular imaging☆Advanced Drug Delivery Reviews, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative AssessmentEnvironmental Health Perspectives, 2007
- Asymmetric Functionalization of Gold Nanoparticles with OligonucleotidesJournal of the American Chemical Society, 2006